SCHEMBL1609466

SCHEMBL1609466

COC(=O)c1nc(C2CC2)nc(NCc2cccc(OC)c2OC)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 2/20 0.41
P2RX7 Q99572 2/20 0.41
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 3/20 0.40
POLB P06746 2/20 0.40
GAA P10253 2/20 0.40
MAPK1 P28482 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PDE10A Q9Y233 1/20 0.40
TSHR P16473 2/20 0.39
PKM P14618 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1610305 0.91 PDE10A (0.44) HIF1ASMN1; SMN2LMNANPSR1MAPT
SCHEMBL12712758 0.90 PDE10A (0.42) SMN1; SMN2ALDH1A1PDE10A
SCHEMBL13769408 0.90 PDE10A (0.44) SMN1; SMN2ALDH1A1PDE10A
SCHEMBL1610064 0.88 PDE10A (0.42) HIF1ASMN1; SMN2ALDH1A1PDE10AROCK1
SCHEMBL1608875 0.85 ALDH1A1 (0.51) SMN1; SMN2LMNAMAPTKDM4EALDH1A1
SCHEMBL12712734 0.84 PDE10A (0.42) PDE10AROCK1JAK3
SCHEMBL1609763 0.84 PDE10A (0.47) SMN1; SMN2LMNAMAPTALDH1A1PDE10A
SCHEMBL1610228 0.83 CHRM3 (0.43) SMN1; SMN2LMNAMAPTP2RX7ALDH1A1
SCHEMBL12738427 0.83 MAPT (0.41) HIF1ASMN1; SMN2LMNANPSR1MAPT
SCHEMBL1610180 0.83 PDE10A (0.42) SMN1; SMN2LMNAKDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086759-A1 CHEMICAL COMPOUNDS DDT, PNPO, CBR3 HIF1A 3397/4885SMN1; SMN2 2654/4885LMNA 4805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.